Literature DB >> 6599950

Comparison of activated charcoal and gastric lavage in the prevention of aspirin absorption.

B T Burton1, M J Bayer, L Barron, J P Aitchison.   

Abstract

Effectiveness of initial treatment of aspirin (ASA) overdosage was evaluated by comparing treatment with activated charcoal (AC) to treatment with gastric lavage in combination with AC. Dogs were used as subjects in four experimental groups. All subjects were administered an overdose of 500 mg/kg of ASA. Treatment was performed 30 minutes later on all groups except controls. Treatment with AC alone resulted in a 17% reduction (P greater than .05) of peak plasma salicylate levels compared with controls. When lavage preceded administration of AC, a 37% reduction (P less than .05) occurred. There was a 48% reduction (P less than .025) in plasma salicylate levels when lavage was preceded and followed by administration of AC. This study demonstrates that gastric lavage in combination with AC is more effective in reducing ASA absorption than AC given alone.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6599950     DOI: 10.1016/0736-4679(84)90203-8

Source DB:  PubMed          Journal:  J Emerg Med        ISSN: 0736-4679            Impact factor:   1.484


  5 in total

1.  Management principles for the overdosed patient.

Authors:  I Vicas
Journal:  Can Fam Physician       Date:  1988-10       Impact factor: 3.275

2.  Activated charcoal, emesis, and gastric lavage in aspirin overdose.

Authors:  V Danel; J A Henry; E Glucksman
Journal:  Br Med J (Clin Res Ed)       Date:  1988-05-28

3.  An evidence based flowchart to guide the management of acute salicylate (aspirin) overdose.

Authors:  P I Dargan; C I Wallace; A L Jones
Journal:  Emerg Med J       Date:  2002-05       Impact factor: 2.740

Review 4.  Activated charcoal--past, present and future.

Authors:  R W Derlet; T E Albertson
Journal:  West J Med       Date:  1986-10

Review 5.  A reassessment of the treatment of salicylate poisoning.

Authors:  L Notarianni
Journal:  Drug Saf       Date:  1992 Jul-Aug       Impact factor: 5.606

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.